Greg Mattingly
MD
Psychiatrist
Washington University

Dr. Mattingly is a physician and principal investigator in clinical trials for Midwest Research Group. He is also a founding partner of St. Charles Psychiatric Associates where he treats children, adolescents and adults. A St Louis native, he earned his medical degree and received a Fulbright scholarship while attending Washington University. Dr. Mattingly is board certified in adult and adolescent psychiatry and is a Diplomat of the National Board of Medical Examiners. He is an Associate Clinical Professor at Washington University where he teaches psychopharmacology courses for the 3rd year medical students. Dr. Mattingly has been a principal investigator in over 400 clinical trials focusing on ADHD, anxiety disorders, major depression, bipolar disorder and schizophrenia. Having served on numerous national and international advisory panels, Dr. Mattingly has received awards and distinctions for clinical leadership and neuroscience research. Dr Mattingly is the President for APSARD-The American Professional Society of ADHD and Related Disorders and is on the Scientific Advisory Board for the Workd Federation of ADHD.. Having served on the board of Headway House, a community support program and as a certifed evaluator for both the NFL and MLB, Dr Mattingly is firm believer in holistic mental health, eductaion and advocacy.

Sessions

Register

Psych Congress Orientation Session (non-CME)

Wednesday, September 17, 2025
7:00 AM - 7:30 AM

Advanced Psychopharmacology Preconference: Four Emerging MOAs In Psychiatry and Their Major Clinical Impact

Wednesday, September 17, 2025
9:00 AM - 12:00 PM

Science, Compassion, and Legacy: Carrying Forward the Lessons of Dr. Vladimir Maletic

Wednesday, September 17, 2025
1:45 PM - 3:15 PM

Rethinking ADHD Prescribing: Navigating ADHD Treatment Amidst a Changing Landscape

Thursday, September 18, 2025
3:00 PM - 4:15 PM

First-Line Decisions: Medication or Lifestyle Modification? Balancing Pharmacologic and Non-Pharmacologic Care in ADHD

Thursday, September 18, 2025
4:30 PM - 5:45 PM

Solving Clinical Challenges: Managing ADHD in High-Risk Populations

Friday, September 19, 2025
9:00 AM - 10:15 AM

Latest Discoveries & Emerging Trends in Neurodevelopmental Disorders

Saturday, September 20, 2025
4:45 PM - 6:00 PM

Generalized Anxiety Disorder in 3 Acts: Prevalence, Mechanisms, and Emerging Treatments

Sunday, September 21, 2025
1:30 PM - 2:45 PM

Psych Congress 2025: Final Thoughts and Panel Discussion

Sunday, September 21, 2025
4:15 PM - 4:30 PM